PL3326619T3 - Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę - Google Patents
Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinęInfo
- Publication number
- PL3326619T3 PL3326619T3 PL17203972T PL17203972T PL3326619T3 PL 3326619 T3 PL3326619 T3 PL 3326619T3 PL 17203972 T PL17203972 T PL 17203972T PL 17203972 T PL17203972 T PL 17203972T PL 3326619 T3 PL3326619 T3 PL 3326619T3
- Authority
- PL
- Poland
- Prior art keywords
- emtricitabine
- tenofovir
- pharmaceutical compositions
- solid oral
- oral pharmaceutical
- Prior art date
Links
- XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 title 1
- 229960000366 emtricitabine Drugs 0.000 title 1
- 239000008203 oral pharmaceutical composition Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 229960004556 tenofovir Drugs 0.000 title 1
- VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2016/17448A TR201617448A2 (tr) | 2016-11-29 | 2016-11-29 | Tenofovi̇r ve emtri̇si̇tabi̇n i̇çeren kati oral farmasöti̇k bi̇leşi̇mler |
| EP17203972.9A EP3326619B1 (en) | 2016-11-29 | 2017-11-28 | Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3326619T3 true PL3326619T3 (pl) | 2022-06-06 |
Family
ID=60569617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17203972T PL3326619T3 (pl) | 2016-11-29 | 2017-11-28 | Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3326619B1 (pl) |
| EA (1) | EA201991286A1 (pl) |
| ES (1) | ES2910924T3 (pl) |
| PL (1) | PL3326619T3 (pl) |
| PT (1) | PT3326619T (pl) |
| TR (1) | TR201617448A2 (pl) |
| WO (1) | WO2018099895A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021091498A1 (en) * | 2019-11-06 | 2021-05-14 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Pharmaceutical compositions comprising tenofovir and emtricitabine |
| CN112274488B (zh) * | 2020-10-22 | 2022-08-26 | 安徽贝克生物制药有限公司 | 一种恩曲他滨、替诺福韦复方片及其制备方法 |
| WO2024211882A1 (en) * | 2023-04-07 | 2024-10-10 | Navinta, Llc | Stable compositions of rilpivirine hcl in combination with other anti-retroviral agents |
| CN119139247A (zh) * | 2024-09-05 | 2024-12-17 | 安徽贝克生物制药有限公司 | 一种恩曲他滨丙酚替诺福韦复方片及制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100860136B1 (ko) * | 2003-01-14 | 2008-09-25 | 길리애드 사이언시즈, 인코포레이티드 | 복합 항바이러스 치료를 위한 조성물 및 방법 |
| ATE474560T1 (de) | 2005-12-14 | 2010-08-15 | Cipla Ltd | Pharmazeutische kombination aus nucleotid und nucleosid-reverse-transkriptase-hemmern (wie tenofovir und lamivudin) in verschiedenen teilen der dosiereinheit |
| WO2008096369A2 (en) * | 2007-02-05 | 2008-08-14 | Matrix Laboratories Limited | Pharmaceutical formulation for use in hiv therapy |
| CA2744211A1 (en) * | 2008-11-21 | 2010-05-27 | Ultimorphix Technologies B.V. | Wet granulation of tenofovir, emtricitabine and efavirenz |
| JP2014500261A (ja) * | 2010-11-19 | 2014-01-09 | ギリアード サイエンシーズ， インコーポレイテッド | リルピビリンＨＣｌおよびフマル酸テノホビルジソプロキシルを含有する治療用組成物 |
| MX351816B (es) * | 2013-01-31 | 2017-10-30 | Gilead Pharmasset Llc | Formulacion de combinacion de dos compuestos antivirales. |
| US20160199396A1 (en) * | 2013-08-29 | 2016-07-14 | Teva Pharmaceutical Industries Ltd. | Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir |
| IN2013CH05288A (pl) * | 2013-11-18 | 2015-09-11 | Aurobindo Pharma Ltd | |
| CZ2013985A3 (cs) | 2013-12-09 | 2015-06-17 | Zentiva, K.S. | Stabilní farmaceutická kompozice obsahující tenofovir disoproxil fumarát |
-
2016
- 2016-11-29 TR TR2016/17448A patent/TR201617448A2/tr unknown
-
2017
- 2017-11-28 EP EP17203972.9A patent/EP3326619B1/en active Active
- 2017-11-28 PT PT172039729T patent/PT3326619T/pt unknown
- 2017-11-28 WO PCT/EP2017/080621 patent/WO2018099895A1/en not_active Ceased
- 2017-11-28 ES ES17203972T patent/ES2910924T3/es active Active
- 2017-11-28 PL PL17203972T patent/PL3326619T3/pl unknown
- 2017-11-28 EA EA201991286A patent/EA201991286A1/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3326619A1 (en) | 2018-05-30 |
| WO2018099895A1 (en) | 2018-06-07 |
| PT3326619T (pt) | 2022-03-25 |
| TR201617448A2 (tr) | 2018-06-21 |
| ES2910924T3 (es) | 2022-05-17 |
| EA201991286A1 (ru) | 2019-10-31 |
| EP3326619B1 (en) | 2022-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256364A (en) | Pharmaceutical formulations containing tenofovir and emtricitabine | |
| DK3720496T3 (en) | Solid oral nicotine formulation | |
| GB201620066D0 (en) | Solid Pharmaceutical dosage formulations and processes | |
| ZA201900275B (en) | Oral gastroretentive formulations and uses thereof | |
| IL256296A (en) | Particles of dimethyl fumarate and pharmaceutical preparations thereof | |
| ZA201903101B (en) | Pharmaceutical formulations | |
| IL266132B (en) | Pharmaceutical formulations and methods for their preparation | |
| SMT202300074T1 (it) | Composizione farmaceutica stabile per somministrazione orale | |
| PT3326619T (pt) | Composições farmacêuticas orais sólidas compreendendo tenofovir e emtricitabina | |
| EP3145508C0 (en) | CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| PT3383397T (pt) | Composições farmacêuticas contendo doravirina, tenofovir disoproxil fumarato e lamivudina | |
| ZA202008034B (en) | Ivosidenib forms and pharmaceutical compositions | |
| SG10202106375UA (en) | Pharmaceutical compositions and use thereof | |
| IL254711B (en) | History of diazepine-indole and medicinal preparations containing them | |
| EP3497080A4 (en) | PHARMACEUTICAL FORMULATIONS AND THEIR USE | |
| IL271908A (en) | Over-compressed pharmaceutical preparations | |
| ZA201903341B (en) | Pharmaceutical compositions and uses thereof | |
| GB201812022D0 (en) | Pharmaceutical methods and compositions | |
| GB201721606D0 (en) | Sustained release oral pharmaceutical compositions of dicycloverine | |
| GB201713920D0 (en) | Pharmaceutical compositions and uses thereof | |
| GB201604810D0 (en) | Pharmaceutical compositions and uses | |
| GB201610440D0 (en) | Pharmaceutical formulations | |
| AU2015901459A0 (en) | Pharmaceutical powder composition and use |